MRNA Filing
4Filing Date: Jun 3, 2026

Moderna, Inc. (MRNA) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001682852-26-000113open_in_new
Total Value$49.4K
Trades3
Insiders1

Transaction Details

Klinger Shannon Thyme
Chief Legal Officer·Direct
Exercise · Acquire
Common Stock
Shares+2.17K
Price-
Total Value$0
Shares Owned After68.52K
Transaction DateJun 1, 2026
Footnotes ▸

Restricted stock units convert into common stock on a one-for-one basis. | Restricted stock units convert into common stock on a one-for-one basis.

Klinger Shannon Thyme
Chief Legal Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-2.17K
Price$0.00
Total Value$0
Shares Owned After23.83K
Transaction DateJun 1, 2026
Footnotes ▸

Restricted stock units convert into common stock on a one-for-one basis. | Restricted stock units convert into common stock on a one-for-one basis. | 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. | 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Klinger Shannon Thyme
Chief Legal Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-1.05K
Price$47.19
Total Value$49.4K
Shares Owned After67.47K
Transaction DateJun 1, 2026
Footnotes ▸

Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.

Post-Transaction Holdings

Klinger Shannon Thyme
SecuritySharesChange
Common Stock68.52K+1.12K (1.66%)
Restricted Stock Units23.83K-2.17K (-8.33%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Klinger Shannon Thyme CIK: 0001866132 Role: Officer (Chief Legal Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-01 | Code: M (Exercise of derivative) Shares: +2,165 Shares Owned After: 68,515 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [Transaction #2] Security: Common Stock Date: 2026-06-01 | Code: F (Payment of exercise/tax) Shares: -1,047 | Price: $47.19 Total Value: $49,407.93 Shares Owned After: 67,468 | Ownership: D (Direct) Footnotes: [F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-06-01 | Code: M (Exercise of derivative) Shares: -2,165 | Price: $0.00 Shares Owned After: 23,827 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [F3] 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [F3] 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Footnotes (Complete Index) --- F1: Restricted stock units convert into common stock on a one-for-one basis. F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3: 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Signature --- /s/ /s/ James Dillon, as Attorney-in-Fact (2026-06-03)

keid analysis is for reference only and does not constitute investment advice.